Topotecan hydrochloride
NDC 45963-615, Topotecan hydrochloride, injection, powder, lyophilized, for solution, from Actavis Pharma, Inc..
- Product NDC
- 45963-615
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090620
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/45963-615 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPOTECAN HYDROCHLORIDE4 mg/4mL
Pharmacologic classes
Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 45963-615-56 | 45963061556 | 1 VIAL in 1 CARTON (45963-615-56) / 4 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/996430c0-ee26-4ed9-82b8-a8b645becba6Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=45963-615
Use it
Look up 45963-615 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/45963-615 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 45963-615. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.